Eldora Capsule (Erdosteine)

Adult dose

Adults: Administer 300 mg of erdosteine orally per dose, 2～3 times daily. When used for acute respiratory disease, do not administer continuously for more than 10 days.

This drug should not be used by individuals allergic to this medication or its components. Patients with liver cirrhosis or cystathionine synthase deficiency should not be administered this drug, as its metabolites may interfere with methionine metabolism. Patients with peptic ulcers should also avoid this medication. Patients with severely impaired kidney function, specifically those with a creatinine clearance of less than 25 mL/min, should not use this drug. Patients with severe liver dysfunction should also refrain from taking this medication. For patients with mild to moderate liver impairment, this drug should be administered with caution, ensuring that the daily dose does not exceed 300 mg. Diabetic patients or those on a low-calorie diet must be cautious when using this drug only in syrup form. Overdosing this drug may lead to symptoms of excessive sweating, dizziness, and facial flushing. Headaches may occur, as well as cold symptoms or difficulty breathing. Gastrointestinal symptoms such as nausea, vomiting, diarrhea, abdominal pain, and heartburn may also arise, so care should be taken. Allergic reactions such as urticaria, red spots, and eczema may appear on the skin. Reported side effects in South Korea include fatigue, indigestion, abdominal pain, diarrhea, vomiting, headache, facial swelling, itching, lethargy, confusion, rash, etc., but a direct connection to this drug is not clear. Taking this medication with cough medicine may result in difficulty expectorating phlegm, increasing the risk of bronchial infections and causing bronchoconstriction, so caution is advised. Animal studies have shown no evidence that this drug harms the fetus or newborn during pregnancy or breastfeeding; however, due to a lack of established safety in pregnant or potentially pregnant women and breastfeeding mothers, it is advisable to avoid its use. This drug should be stored in a safe place away from children's reach, and it is best to keep it in the original container to prevent accidents or deterioration of the drug's quality.

• sweating
• dizziness
• flushing
• headache
• cold
• shortness of breath
• taste disturbance
• nausea
• vomiting
• diarrhea

Drug interactions

This drug should be taken with cough medicine only after consulting with a doctor or pharmacist.

This drug should be stored in a tightly sealed container to protect it from air and light exposure, and it is advisable to maintain storage temperatures at normal room temperature. This is to preserve the drug's efficacy and prevent deterioration.

Appearance

A hard capsule with upper and lower light green parts containing white or pale yellow powder

Package unit

30 capsules/bottle, 300 capsules/bottle, 10 capsules/blister